Filing excerpt
As reported in a Current Report on Form 8-K filed by the Company on March 2, 2026, the Company was notified by the Centers for Medicare & Medicaid Services (“CMS”) on February 27, 2026 of its intent to impose intermediate sanctions suspending enrollment of Medicare beneficiaries into the Company’s Medicare Advantage-Prescription Drug plans and suspending certain communication activities to Medicare beneficiaries effective as of March 31, 2026 (the “Sanctions”), unless CMS determines the issues identified have been satisfactorily addressed.